Not applicableStudy completedNCT03675997What this trial is testingGRAFted Patients' anxieTY ReportWho this might be right forAutologous Transplant Indication Institut de Cancérologie de la Loire 30
Testing effectiveness (Phase 2)UnknownNCT03315520What this trial is testingBeEAC Conditioning Regimen in Malignant Lymphoma Subjects With Indications to Autologous Hematopoietic Stem-cell TransplantationWho this might be right forRelapsed/Refractory Malignant Lymphomas State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 100
Testing effectiveness (Phase 2)Looking for participantsNCT04276870What this trial is testingOrphan Indications for CD19 Redirected Autologous T CellsWho this might be right forPediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation Stephan Grupp MD PhD 133
Not applicableUnknownNCT06507800What this trial is testingCancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada?Who this might be right forAutoimmune Diseases Assistance Publique - Hôpitaux de Paris 500
Not applicableUnknownNCT05540197What this trial is testingArginine-stimulated Indication of Early Outcome After Islet TransplantationWho this might be right forIslets of Langerhans TransplantationDiabetes MellitusChronic Pancreatitis Leiden University Medical Center 30
Not applicableUnknownNCT01702051What this trial is testingExtending Indication for Islet Autotransplantation in Pancreatic SurgeryWho this might be right forDiabetes Ospedale San Raffaele 150